Vaccines very effective against hospital and ICU admissions, also for Delta variant COVID-19 vaccines work well in preventing people from being admitted to hospital or ICU for COVID-19, according to a new analysis by RIVM.
COVID-19 vaccination reduces transmission Vaccination against COVID-19 reduces the transmission of the virus from one person to another. This is apparent from RIVM research using data from source and contact tracing by the Municipal Public Health Services (GGDs).
Nearly 85% of people aged 18 and over have had at least one vaccination The RIVM vaccination update this week has been expanded to include three maps of the Netherlands. For the first time, it is now possible to see vaccination turnout by municipality for everyone aged 18 years and over.
Hospital admissions appear to have peaked, 44% fewer positive COVID-19 tests 541 new COVID-19 hospital admissions were reported last week, 23 fewer than in the week before, when 564 people with COVID-19 were admitted to hospital.
Air quality improved slightly in 2018 In 2018, the calculated concentrations of particulate matter (PM10 and PM2.5) and nitrogen dioxide (NO2) were below European limit values in most parts of the Netherlands. There are still a few exceedances at the local level.
Interim injunction decision Nitrogen In an interim injunction proceeding between Mesdag Zuivelfonds, Stichting Stikstofclaim and RIVM, the court has ruled that RIVM must decide on the availability and disclosure of data before 1 Janua
Two imported cases of Lassa virus in the Netherlands from Sierra Leone Two Dutch doctors working in a hospital in Sierra Leone have been infected with the Lassa virus. The doctors were probably infected during treatment of the same patient.
A pregnant woman can protect her baby against whooping cough with 22-week vaccination From 16 December 2019, pregnant women in the Netherlands will be offered the 22-week vaccination. With this vaccination, a pregnant woman protects her child and herself against whooping cough.
How to distinguish a dual user from an exclusive e-cigarette user RIVM and Maastricht University have identified a combination of factors that can be used to distinguish between exclusive e-cigarette users (vapers) on the one hand and people who smoke both regula
Towards a sustainable, healthy future for everyone: EU project INHERIT offers policy solutions Today, on 10 December a policy toolkit will be presented at the final conference of the European four-year research project INHERIT.